Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Medicine and Dentistry

• Major Bleeding 100%
• Rivaroxaban 80%
• Apixaban 80%
• Combination Therapy 60%
• Inpatient 40%
• Ordering 40%
• Body Weight 20%
• Thrombosis 20%
• Population Research 20%
• Blood Stasis 20%
• Drug Dose Titration 20%
• Enalapril Maleate 20%
• Evaluation Study 20%
• Clinical Intervention 20%
• Age 20%
• Laboratory 20%
• Association 20%
• Assessment 20%
• Adult 20%
• Patient 20%
• Monitoring 20%
• Patient Characteristics 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Rivaroxaban 80%
• Apixaban 80%
• Drug Concentration 20%
• Thrombosis 20%
• Enalapril Maleate 20%